Amid the global response to the challenges posed by COVID-19, a comprehensive understanding of the NLRP3 inflammasome’s mechanisms and the evolving landscape of related inhibitors holds significant promise in guiding treatment approaches and curbing disease progression. The gene discussed is NLRP3; the disease is COVID-19.